Introduction
Gangliosides, sialic acid-containing glycosphingolipids play important roles in the development (Schengrund, 1990) , cell differentiation (Fenderson et al., 1990) and cell proliferation (Hakomori, 2002) . Therefore, expression profiles of gangliosides during the development and cell transformation of various tumors have been widely investigated. All these results indicate that carbohydrate structures in gangliosides are implicated in the determination of cell fates based on the modulation of intracellular signals (Hakomori, 1990) .
A disialoganglioside GD3 has been considered to be associated with neuronal cell proliferation in the early stage of neural development based on the spatiotemporal expression pattern (Yu et al., 1988) . GD3 was also found to be expressed in malignant melanocytes, namely melanoma tumors (Portoukalian et al., 1979; Carubia et al., 1984) , and has been considered to be a human melanoma marker (Pukel et al., 1982) . In fact, GD3 is expressed in majority of melanoma cell lines and melanoma tumors, whereas it can be scarcely detected in normal melanocytes (Furukawa et al., 1990) . Thus, GD3 has been used as a target molecule in immunotherapy with antibodies (Houghton et al., 1985) .
As we isolated cDNAs for GD3 synthase (a2,8-sialyltransferase, a2,8-ST) (Haraguchi et al., 1994) , mechanisms for GD3 expression in human T-cell acute lymphoblastic leukemias were analysed (Okada et al., 1996) . Its role in a rat pheochromocytoma cell line, PC12 was also studied, showing that GD3 synthase expression-induced constitutive activation of NGF receptor TrkA and MAP kinases . In our recent study, it was clarified that specific expression of GD2 in human small cell lung carcinoma (SCLC) cells was caused by specific expression of a2,8-ST gene, and GD2 expression brought about malignant properties of SCLC cells such as rapid proliferation and increased invasion (Yoshida et al., 2001) . Moreover, anti-GD2 monoclonal antibodies (mAbs) could induce apoptosis of SCLC cells, indicating that anti-GD2 mAbs are promising approach to treat SCLC patients (Yoshida et al., 2001) .
Small interfering (si) RNAs were detected first in the small organism as a regulatory machinery of gene expression (Fire et al., 1998) , and is considered to be a common defense system conserved among many species (Waterhouse et al., 2001) . Recent advances in the understanding of siRNAs have enabled us to suppress specific genes in mammalian cells (Elbashir et al., 2001) , and siRNAs are expected to develop gene-specific drugs (Barik, 2004) and as a tool for cancer gene therapy (Izquierdo, 2005) . The objectives as targets of siRNA include signaling molecules, transcription factors and viral components (Scherer and Rossi, 2004) . On the other hand, there have been no sufficient reports on the regulation of glycolipid expression on cell surface using siRNAs except the case of b1,3-galactosyltransferase family (beta 3GalT6) (Bai et al., 2001 ). This might be partly because sugar chains on proteins and lipids are indirect products of glycosyltransferase genes, and slightly hard to be straightly regulated by the suppression of expression levels of their mRNAs. Lifespans of glycosylated molecules on the cell surface may be longer than non-glycosylated molecules present in the cytoplasm and nucleus, making it difficult to regulate expression levels of glycosphingolipids with siRNAs.
In the present study, we tried to suppress GD2 expression using siRNAs against a2,8-ST. The obtained results indicate that repeated transfection of siRNA or stable expression of an expression vector to generate siRNA in the transfectant cells are effective to suppress GD2 expression levels in human lung cancer cell lines, leading to the attenuation of malignant tumor properties.
Results
The glycolipid profiles, growth rates and invasion activities of two lung cancer cell lines To demonstrate the differences in the properties between two human lung cancer cell lines, expression levels of GD2, cell proliferation examined by 3- [4, 5] dimethylthiazol-2, 5-diphenyltetrazolium bromide (MTT) assay, and invasion activity as analysed by Boyden chambers were shown (Figure 1) . Generally, ACC-LC-171 cells showed higher GD2 expression, higher migration, but slower proliferation than ACC-LC-91 cells.
The transfection efficiency and duration of the siRNA expression To examine the transfection efficiency and duration of the siRNA expression, fluorescein-labeled luciferase siRNA duplex was transfected into two cell lines and changes after the transfection were observed under microscope. Efficiency of the transfection in ACC-LC-171 was near 100%, and strong fluorescence could be observed for 3 days. However, the fluorescence positive rate declined to about 50% of cells on the fifth day and to 40% on the seventh day (Figure 2 ). The transfection efficiency in ACC-LC-91 was also examined, showing about 67% positive cells even in the early stage after the transfection (data not shown).
Reduced expression levels of GD2 observed by flow cytometry GD2 expression in ACC-LC-171 was observed during repeated transfection for 2 weeks. GD2 expression in the transfectant cells with siRNA 4 was mostly decreased as compared with control siRNA or siRNA 1-3 (Figure 3a) . Moreover, mRNA levels of a2,8-ST were also definitely decreased in the transfectants with siRNA 4 (Figure 3b) . Then, the expression levels of GD2 were investigated during the repeated transfection of siRNA 4. A reduced expression level of GD2 was observed Knockdown of a2,8-ST mRNA and suppression of GD2 expression We compared mRNA levels of a2,8-ST in the transfectants with siRNA 4 or luciferase siRNA during the repeated transfection into ACC-LC-171 and ACC-LC-91 for 2 weeks using reverse transcription-polymerase chain reaction (RT-PCR). The expression levels of a2,8-ST mRNA showed a decrease in both ACC-LC-171 and ACC-LC-91, although the a2,8-ST mRNA levels in ACC-LC-91 was entirely less than that of ACC-LC-171 ( Figure 5a ). As for the glycolipid products, a reduced GD2 expression was also observed in both cell lines after the repeated transfection with siRNA 4 (Figure 5b) . However, the change in ACC-LC-91 was less than that in ACC-LC-171. Mild increase of GM3, a precursor of GD3, and minimal reduction of GD1b were observed (data not shown).
Recovery of the expression levels of a2,8-ST mRNA and GD2 after ceasing the siRNA transfection The recovery of mRNA and GD2 after ceasing the repeated transfection was investigated by using ACC-LC-91. mRNA expression was analysed at 2, 4 and 6 days after the last transfection ( Figure 6 ). Although mRNA expression was still suppressed at the second day, it restored to the levels of the control at the fourth day. GD2 expression was analysed at 1, 5 and 9 days after the last transfection (Figure 6b, c) . A decrease in GD2 expression was recognized until day 5.
Suppression of the cell growth and invasion by a2,8-ST siRNA Effects of a2,8-ST siRNA on the cell growth were then examined by the repeated transfection into ACC-LC-171 and ACC-LC-91 for 2 weeks. The cells transfected with a2,8-ST siRNA showed an obvious suppression in the proliferation and invasion activity (Figure 7a, b) . Especially, the invasion activity was markedly decreased in both cell lines to one-fifth or less of the individual controls. On the other hand, no effect of siRNA was seen in the cell motility (Figure 7c ).
Induction of apoptosis by a2,8-ST siRNA DNA fragmentation during the repeated transfection of a2,8-ST siRNA in ACC-LC-91 was examined. After the first and third transfections, cells were harvested and served for the analysis of DNA fragmentation. ACC-LC-91 transfected with luciferase siRNA was used as a control. DNA ladder formation could be detected after the third transfection, whereas there was no ladder after the first transfection or in the control (Figure 8 ). . Not only GD2 but also GD1b and GT1b showed apparent reduction in these transfectant cells. Relative expression levels of GD2 in these cell lines as analysed by their mean values were presented in Figure 10a . Relative mRNA levels of GD3 synthase gene were also shown in Figure 10b , showing clear reduction in the transfectants in each group. On the other hand, mRNA levels of GM2/GD2 synthase showed no essential changes (Figure 10c ), indicating the specific effects of a2,8-ST RNAi. Moreover, suppression of GD3 synthase protein was also observed in immunoblotting ( Figure 10d ).
Suppression of the cell growth and invasion in the stable transfectant cells of a2,8-ST RNAi
In those stable transfectants of RNAi, similar phenotypic changes were observed as the transient transfectants of a2,8-ST siRNA. In both ACC-LC-171 and ACC-LC-91 cells, stable transfectants of RNAi showed suppressed proliferation and invasion activity ( Figure  11a , b), whereas they showed no change in the cell motility ( Figure 11c ).
Reduced cell growth of the stable transfectant cells in vivo
In order to observe the tumor growth in vivo, two stable transfectant clones and two control cell lines of ACC-LC-91 were injected into bilateral thigh of four severe combined immunodeficiency (SCID) mice (n ¼ 8).
The numbers of successful inoculation were vec 4 (n ¼ 7), vec 10 (n ¼ 8), GD3i 6 (n ¼ 8) and GD3i 48 (n ¼ 4). Stable transfectants of RNAi showed significantly suppressed cell growth in SCID mice (Po0.05) ( Figure 12 ).
Discussion
Although a number of trials to apply siRNAs for the therapy of cancers have been reported (Izquierdo, 2005) , few studies to knock down carbohydrate antigens relevant with tumor properties have been performed to date. After the transfection of siRNA for a2,8-ST, mRNA of the gene was quickly suppressed as expected.
On the other hand, a2,8-ST siRNA did not affect GD2 expression promptly, whereas gradually reduced GD2 expression could be observed. Ceasing the repeated treatment with siRNA resulted in gradual restoration of GD2 expression. These results reflect relatively slow turnover of glycosphingolipid antigens on the cell surface membrane. Previously, we reported that a glycolipid antigen needed about 3 weeks to completely disappear from the cell surface membrane after disruption of the synthetic pathway (Furukawa et al., 1990) . Eventually, siRNA approach targeted to glycosyltransferase genes needs repeated transfection and relatively long time to achieve significant suppression of the expression levels of their products. Therefore, stable transfectant cells with an RNAi expression vector appeared to show more efficient results in the stable siRNA of GD3 synthase gene for therapy of lung cancers K Ko et al suppression of GD2 as well as a2,8-ST mRNA. In fact, the stable expression of RNAi expression vector for GD3 synthase gene could induce more effective knockdown of GD2 expression. Two lung cancer cell lines used in this study, showed largely different properties in various aspects as shown in Figure 1 . The expression levels of GD2 and a2,8-ST gene were generally higher in ACC-LC-171 than in ACC-LC-91, suggesting that ACC-LC-91 might be more sensitive to the knockdown effects of a2,8-ST siRNA. However, the suppression rates in both GD2 expression and a2,8-ST mRNA were more eminent in ACC-LC-171. This seemed partly due to the lowtransfection efficiency in ACC-LC-91. Nevertheless, ACC-LC-91 cells showed almost equivalent suppressive effects owing to the knockdown of a2,8-ST. Eventually, changes in biological natures owing to the knockdown of a2,8-ST mRNA were not necessarily parallel with the degree of downregulation of GD2 expression and/or a2,8-ST mRNA. This might be because there are a number of factors to determine the relative importance of a glycolipid in the regulation of signals for the individual phenotypes, and those profiles vary depending on the cell lines.
The frequency to obtain GD2-suppressed clones was actually very low owing to unknown reason. This may be relevant with the fact that repeated transfection of siRNA for a2,8-ST gene induced cell apoptosis as shown in Figure 8 . Namely, stable expression of the RNAi expression vector might be very effective to suppress the a2,8-ST gene expression and hardly allow transfectant cells to survive. Consequently, only transfectant cells that underwent partial suppression of a2,8-ST gene might be able to grow under G418 selection. If this is not the case, the RNAi expression vector might be very difficult to be integrated in the host genome for some unknown reason.
Some of gangliosides have been considered to be tumor markers, but also been thought to be functional molecules mediating cell signals involved in the tumor cell properties. Recently, we reported GD2 expression was involved in the enhanced proliferation and invasiveness of SCLC cell lines (Yoshida et al., 2001) . We also reported that anti-GD2 mAbs could induce apoptosis of SCLC cell lines via dephosphorylation of focal adhesion kinase and activation of p38 (Aixinjueluo et al., 2005) . Thus, anti-GD2 mAb might be a promising approach for the therapy of SCLC. However, clinical application of mAbs needs careful investigation especially about side effects based on the crossreaction of mAbs with similar antigens on normal tissues. Use of siRNA of a2,8-ST might be more safety as the target of siRNA therapy is designed for specific sequences present only in the human a2,8-ST gene. In fact, the apoptosis caused by repeating the transfection was specific for the siRNA of GD3 synthase as shown in Figure 8 , and the knockdown effects of anti-a2,8-ST gene RNAi was specific for GD3 synthase, but not for GM2/GD2 synthase as shown in Figure 10b , c. Consequently, when anti-ganglioside mAbs have possibilities to cause adverse tissue damages, siRNAs for the enzyme genes responsible for the synthesis of individual gangliosides might be a promising alternative choice.
As for the mechanisms for the gangliosides to enhance malignant properties in tumor cells have not been sufficiently understood. Recently, Aoki et al. (2004) reported that suppression of GM2/GD2 synthase caused inhibition of motility and invasiveness of a renal cell carcinoma line . They did not analyse the mechanisms for intracellular signaling alteration. Our group demonstrated that GD3 enhances malignant properties of human melanoma cells via the increased tyrosinephosphorylation of p130Cas and paxillin . As growth rates of the RNAi-transfectant cells in SCID mice were apparently reduced as shown in Figure 12 , expression of growth-related genes such as extracellular-signal-regulated kinases and phosphoinositide 3-kinase should be modulated by the knockdown of a2,8-ST. Protein modification (such as phosphorylation and dephosphorylation) of those signaling molecules might also be caused by the treatment. How siRNA of a2,8-ST gene modulates cellular signals involved in the malignant properties in human lung cancer cells remains to be investigated. siRNA of GD3 synthase gene for therapy of lung cancers K Ko et al
Materials and methods

Cell lines and transfection
Human lung cancer cell lines (ACC-LC-171, ACC-LC-91) were provided by T Takahashi (Aichi Cancer Center, Nagoya, Japan). They were maintained in RPMI 1640 containing 10% fetal bovine serum, penicillin and streptomycin in a humidified 5% CO 2 atmosphere at 371C. The day before transfection, ACC-LC-171 cells were plated at a density of 3 Â 10 6 per 60-mm dish, and ACC-LC-91 cells were at 2 Â 10 6 in 5 ml RPMI1640 without antibiotics. Twenty-four hours later, transient transfection was carried out using Lipofectamine2000 (Invitrogen Co., Carlsbad, CA, USA). Twenty microliters Lipofectamine2000 and 500 ml opti-MEM TM medium (Invitrogen) without serum were preincubated for 5 min at room temperature. During the incubation time, 0.6 nmol siRNA was mixed with 500 ml opti-MEM TM . These two mixtures were combined and incubated for 20 min at room temperature for complex formation, and the mixture was added to the dish.
After 4 h incubation in the CO 2 incubator, the medium containing siRNA-Lipofectamine 2000 complexes was replaced with growth medium without antibiotics. When repeated transfection was needed, cells were replated at 48 h after the last transfection, and were transfected again with the same protocol.
siRNA preparation
The sequences of siRNA for human a2,8-sialyltransferase (GenBank Accession No. L32867) were designed by B-Bridge International Inc. (Sunnyvale, CA, USA). Four candidate sequences were detected (Table 1) . Selected siRNA sequences were also submitted to a BLAST search against the human genome sequence to ensure the target specificity. As a nonspecific siRNA control, a sequence targeting firefly (Photinus pyralis) luciferase gene (X65324) 153-175 was used. The RNA duplexes were synthesized by B-Bridge International Inc. (Sunnyvale, CA, USA). siRNA of GD3 synthase gene for therapy of lung cancers K Ko et al Quantitative real-time RT-PCR analysis Total RNA was isolated from each transfectant using ISOGENt (Invitrogen) according to the manufacturer's instructions. cDNA was synthesized from 3 mg total RNA using M-MLV reverse transcriptase with oligo dT (Invitrogen). Each cDNA was diluted with water 5 times, and 2 ml were mixed to 20 ml PCR reaction mixture using DyNAmo SYBR Green qPCR Kitt (BioRad, Hercules, CA, USA). The primers used for a2,8-ST (Haraguchi et al., 1994) were a forward primer (GenBank L32867, nucleotides 382-401), 5 0 -GTGGTATGACGGGGAGTTTT-3 0 , and a reverse primer (nucleotides 839-858), 5 0 -GGCATGGATTCCTCTACTTT-3 0 . The primers for glyceraldehydes 3-phosphate dehydrogenase (GAPDH) were a forward primer (nucleotides 795-814), 5 0 -GTCAGTGGTGGACCTGACCT-3 0 , and a reverse primer (nucleotide 1020-1039), 5 0 -TGCTGTAGCCAAATTCGTTG-3 0 . RT-PCR reactions were performed on Opticon2t (BioRad). The relative expression level was deduced from a standard curve constructed using the positive sample and normalized with the expression level of GAPDH in each sample. The sizes of the PCR products were confirmed by agarose gel electrophoresis using pUC19 (digested with HaeIII) as a standard.
Western immunoblotting
The cells were plated in 60-mm tissue culture plates in serumcontaining medium. After the cells were incubated, the siRNA of GD3 synthase gene for therapy of lung cancers K Ko et al medium was removed, and the cells were washed three times with 3 ml of serum-free medium and then solubilized in 200 ml of lysis buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10 mM MgCl 2 , 0.5% Nonidet P-40, I mM phenylmethylsulfonyl fluoride, 20 units/ml aprotinin). Lysed cells were centrifuged at 3000 r.p.m. for 10 min, and then lysates were subjected to 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins were transferred electrophoretically onto a polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA) and immunoblotted with an antibody reactive with human GD3 synthase as described previously . The GD2 expression of ACC-LC-171 transfectants (GD3i 28, GD3i 33) was obviously decreased compared with the controls (vec10, vec12). Furthermore, other b-series gangliosides (GD1b and GT1b) were also markedly decreased. As for ACC-LC-91, b-series gangliosides including GD2, GD1b and GT1b were also decreased in the transfectants (D3i 6, GD3i 48), whereas their changes were less than those in ACC-LC-171 transfectants.
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Flow cytometry
The cell surface expression of ganglioside GD2 was analysed by flow cytometry using FACScant (Becton Dickinson, Mountain View, CA, USA) using an anti-GD2 mAb (mAb 220-51, mouse IgG3). The cells were incubated with the mAb for 40 min on ice and then stained with fluorescein isothiocyanate-conjugated goat anti-mouse IgG (Cappel, Durham, NC, USA) for 30 min. Control cells for flow cytometry were prepared using the second antibody alone. For quantification of positive cells, CELLQuestt program was used.
MTT assay
For cell proliferation assay, transfectant cells and control cells (4 Â 10 3 cells/well) were prepared in 96-well plates in serumcontaining medium. On days 1, 3 and 5 after the plating, MTT (Sigma Chemical Co., Tokyo, Japan) was added to each well (100 mg/well). After incubation for 4 h at 371C, the supernatants were aspirated, and 100 ml of n-propyl alcohol containing 0.1% NP40 and 4 mM HCl were added. The color reaction was quantified using an automatic plate reader, Immuno-Mini NJ-2300t (Nihon InterMed, Tokyo, Japan), at 590 nm with a reference filter of 620 nm as reported previously (Kojima et al., 2000) .
In vitro invasion assay
The Boyden chamber in vitro invasion assay was performed as described previously (Damstrup et al., 1998) with some modifications. In brief, Matrigelt (Becton Dickinson) was diluted with ice-cold phosphate-buffered saline (200 mg/ml), added to each filter (190 mg/filter; polyethylene terephthalate , and left to polymerize and dry overnight. The polymerized and dried Matrigel membranes were reconstituted with serum-free medium. The lower chamber (six-well plate; Falcon 3502) was filled with serumfree medium (3 ml) before the chamber was assembled. Cells (1 Â 10 5 cells/well) were added to serum-free medium in the upper chamber and incubated for 24 h in a humidified 5% CO 2 atmosphere at 371C. After incubation, the cells on the upper surface of the filter were completely removed by wiping with a cotton swab. The filters were fixed in ethanol for 30 min and stained with Giemsa (Wako Pure Chemical Industries, Osaka, Japan) for 30 min. The number of cells migrating to the lower surface of the filters was counted in 10 fields under Â 200 magnification, and the mean of the number in each field was calculated. Assay was carried out in triplicate.
In vitro motility assay To analyse the two-dimensional motility, a wound-healing scratching mobility assay was performed as described by Hauck et al. (2002) . Cells (8 Â 10 6 ) were plated in 60-mm dishes (Falcon), and scratching was performed on the next day using a plastic tip. Taking pictures under a microscopy, the areas newly occupied with moved cells in the scratched spaces were measured at 0, 5, 10, 20 and 30 h after the scratching.
Construction of an RNAi expression plasmid and introduction into cell lines
To construct vectors for expression of RNAi, we used the pH1-RNApuro as described previously (Takamizawa et al., 2004) . This plasmid includes the site of HindIII and BglII at the downstream of human H1 promoter. Chemically synthesized oligonucleotides encoding the sequences to express GD3 synthase siRNA (5 0 -GAT CCC CGA TAG GAA TAG AGT CAT CTT TCA AGA GAA GAT GGC TCT GTT CCT GTC TTT TTG GAA AA-3 0 and 5 0 -AGC TTT TTC CAA AAA GAC AGG AAC AGA GCC ATC TTC TCT TGA AAG ATG ACT CTA TTC CTA TCG GG-3 0 ) were synthesized and annealed (Nippon EGT Co., Toyama, Japan). The product should contain a loop region as shown with underlines (Brummelkamp et al., 2002) . When these oligonucleotides were combined, this sequence had HindIII and BglII linker site that can be used for the insertion into the vector without any treatment. The plasmids containing the insert to express a2,8-ST siRNA were confirmed by DNA sequencing and transfected into ACC-LC-171 and ACC-LC-91 cells using the Lipofectamine 2000t (Invitrogen) as described above for siRNA transfection. The transfected cells were maintained in RPMI 1640 containing 0.5 mg/ml puromycin after the transfection to isolate single clones of stable transfectants. Eighty colonies were screened by flow cytometry analysis using the mAb 220-51. The cell lines transfected with pH1-RNApuro without insert was used as a control.
DNA fragmentation assay
At 24 h after the transfection, cells were harvested and lysed in 100 ml of a lysis buffer (10 mM Tris-HCl pH 7.4, 10 mM ethylene-diaminetetraacetic acid (EDTA), and 0.5% Triton X-100) for 10 min at 41C. After centrifugation, the supernatants were collected, and 2 ml of RNAase (10 mg/ml) and 2 ml of Proteinase K (10 mg/ml) were added. After incubation for 1 h at 371C, the fragmented DNA was precipitated in 2-propanol and electrophoresed on a 2% agarose gel containing 0.2 mg/ml ethidium bromide in TAE buffer (40 mM Trisacetate, 1 mM EDTA). The gel was observed under UV light.
Tumor growth assay in mice
To evaluate the effect of GD2 suppression to the tumor growth in vivo, stable transfectant cells of a2,8-ST RNAi were injected into SCID mice. A total of 1 Â 10 7 transfectant cells were subcutaneously inoculated in 0.2 ml of serum-free RPMI1640 into bilateral thigh of 8-week-old SCID mice from Charles River Japan (Yokohama, Japan). Tumor size was measured with a caliper twice a week. The tumor volume was estimated according to the formula: volume (mm
, where L and W are the length and width of the tumor, respectively. siRNA of GD3 synthase gene for therapy of lung cancers K Ko et al
